Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-26

FDA Approved: WARFARIN SODIUM — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Warfarin Sodium by Exelan Pharmaceuticals. This action updates the regulatory status of this generic anticoagula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

SUPPL AP for WARFARIN SODIUM (WARFARIN)